Why BGPT?
logo

Tables Built From Reported Results

Assemble tables from exact reported values and versioned claims, with provenance back to every source paper.Know what falsifiable science actually supports before you trust the answer.

Press Enter ↡ to search evidence


     Long Analysis Plan



    Tables from the Tanzanian NICU Point-Prevalence Study (10.1093/jacamr/dlaf179)

    A one-day point-prevalence survey (17 May 2022) at Muhimbili National Hospital's level III NICU (100 beds) screened 51 inborn neonates (mean gestational age 31.6 Β± 3.8 weeks; median age at sampling 8 days, IQR 11; 41% female) via rectal swabs, with ESBL confirmation by combination disk testing, WGS on Illumina NovaSeq 6000, and Optical DNA Mapping (ODM) of plasmids using Cas9 targeting of blaNDM-5 or blaCTX-M-15.

    Table 1 β€” Colonization counts (EPE and CPE)

    CategoryOrganismCount (n)
    Screened neonatesAll51
    EPE-colonized neonatesAny ESBL-producing Enterobacteriaceae31 (60.7%)
    EPE isolatesESBL-producing E. coli (EP-EC)19
    EPE isolatesESBL-producing K. pneumoniae (EP-KP)21
    EPE isolatesESBL-producing K. oxytoca (EP-KO)1
    Carbapenem-resistant isolatesK. pneumoniae10
    Carbapenem-resistant isolatesE. coli4
    Carbapenem-resistant isolatesK. oxytoca1
    Carbapenem-resistant isolates (total)All species15

    Note: isolate counts across species can exceed the 31 colonized neonates if a neonate carried more than one species; the paper does not report per-neonate co-carriage breakdowns (BGPT inference β€” flagging a known unknown).

    Table 2 β€” Genotype carriage among the 15 carbapenem-resistant isolates

    GeneCarriageInterpretation (author-reported)
    blaNDM-515/15 (100%)Universal in all carbapenem-resistant isolates
    blaCTX-M-1515/15 (100%)Universal; not plasmid-borne in the investigated ODM plasmids
    blaOXA-1818/15 (53%)Present in subset, co-carried with NDM-5 and CTX-M-15

    Clonal types detected: K. pneumoniae ST437 (CC11), ST392, ST147; E. coli ST167; K. oxytoca carried blaNDM-5/blaCTX-M-15 with one KO isolate unassigned for ST.

    Table 3 β€” ODM plasmid subset details (n = 6 plasmids)

    ParameterDetail
    Isolates analyzed4 K. pneumoniae ST437 + 2 E. coli ST167
    Plasmid sizes58–211 kb
    Mean plasmid size~151.4 kb
    blaNDM-5 locationPlasmid-borne in all 6 analyzed plasmids
    blaCTX-M-15 locationNot plasmid-borne in investigated plasmids
    Plasmid similarityHighly similar (P < 0.001), suggesting plasmid transfer across species
    MethodODM with Cas9 targeting blaNDM-5/blaCTX-M-15; MATLAB analysis; YOYO-1/netropsin staining

    Table 4 β€” Phenotypic susceptibility (%) among EPE isolates (disk diffusion, EUCAST v13.1)

    E. coli (n=19): piperacillin-tazobactam 47%, meropenem 31%, ertapenem 31%, imipenem 26%, amikacin 26%, gentamicin 47%, trimethoprim-sulfamethoxazole 84%, ciprofloxacin 63%. K. pneumoniae (n=21): PTZ 62%, MEM 38%, ETP 43%, IMI 43%, amikacin 24%, gentamicin 57%, SXT 95%, ciprofloxacin 71%. These values correspond to the bar chart above; the paper reports only these percentages without confidence intervals.

    Limitations: single-site, single-day design; n=51; descriptive only with no risk-factor analysis; incomplete AWaRe data; ODM restricted to a 6-plasmid subset; cot-sharing incompletely captured β€” all stated by the authors. Confidence in the tabulated values is high (direct extraction), but generalizability beyond this NICU is limited by design.



    Feedback:    

    Updated: October 26, 2026

     Top Data Sources ExportMCP



     Analysis Wizard



    Compiling the NICU study's colonization counts, resistance gene carriage, and ODM plasmid subset into structured, analyzable tables for AMR surveillance comparison and cross-study visualization.



     Science Art


    Create Tables: EPE/CPE counts, genotype carriage, ODM subset details from 10.1093/jacamr/dlaf179 Science Art

     Science Movie



    Make a narrated HD Science movie for this answer ($64 per minute)




     Discussion


    Stay current without chasing every paper.

    Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.


    My BGPT